P Bevan

发表

TECHNOLOGY AND TRAFFIC MANAGEMENT

P Bevan, 1995 .

Identifying small-molecule lead compounds: the screening approach to drug discovery.

P Bevan, H. Ryder, P. Bevan, 1995, Trends in biotechnology.

Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.

P Bevan, A. Stewart, P. Bevan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.